glp 1 for eating disorders New research from our team highlights the growing use of GLP-1 medications among individuals with disorders. Published in JAMA Psychiatry, the study found that more than half of patients… GLP-1RAs Reduce External Eating Behavior

The table below distinguishes herbal metabolic support from clinically proven GLP-1 strategies, using biomarker changes and clinical evidence as the framework

Monitoring focuses on glucose handling, IGF-axis context, cardiovascular risk, and symptoms that may suggest excessive pathway activity

1 Trimethylamine N-oxide (TMAO) is a significant metabolite generated from dietary components by gut microbes through microbial enzymes (such as trimethylamine lyases)

Powders dissolve instantly in water, tablets can be taken on the go, and ready-to-drink formats require zero preparation

But like any treatment, they can come with side effects especially in the first few weeks or when increasing your dose